Literature DB >> 2418718

[Torsades de pointes and hypomagnesemia].

T Marsepoil, F Blin, F Hardy, G Letessier, J L Sebbah.   

Abstract

The authors report a case of "Torsades de pointe" occurring in a patient subjected to intensive surgical care and presenting several causes of magnesium loss: mutilating abdominal surgery, exteriorized gastric fistula, administration of Henle's loop diuretics, electrolytic disorders and exclusive parenteral nutrition without any magnesium Mg supplement. The arrhythmia appeared in the third week and the usual treatment was ineffective. The level of plasma magnesium was below the measurable values on three separate occasions. The administration of magnesium sulphate corrected the dysrhythmia which did not recur. Experimental and clinical data demonstrating the antiarrhythmic effect of magnesium are recalled. The electrophysiological explanation is based on the inhibition of potassium and calcium flow across the cell membrane; magnesium ion has a stabilizing membrane effect and an antagonistic effect on ectopic automaticity. They are particularly important on slowly depolarizing tissue (nodal cells) or partially depolarized cells (ischaemic or digitalis treated cardiac tissue). In intensive care, circumstances for magnesium depletion by digestive or renal losses and by lack of parenteral magnesium supplement are frequently combined. Systematic intravenous administration of magnesium is necessary when such conditions are found and whenever ventricular or auricular dysrhythmias occur.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2418718     DOI: 10.1016/s0750-7658(85)80253-7

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  2 in total

1.  Hypomagnesemia and cardiovascular system.

Authors:  G Efstratiadis; M Sarigianni; I Gougourelas
Journal:  Hippokratia       Date:  2006-10       Impact factor: 0.471

2.  Elevated plasma free fatty acid concentrations do not modify cardiac repolarization in patients treated by electrolyte-glucose-insulin infusion.

Authors:  F Nappo; M Loreto; G Giugliano; E Grella; K Esposito; B Lettieri; D Giugliano
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.